Resveratrol inhibits TGF-B1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway
Deng, Li; Zou, Jun; Su, Yongfeng; Wang, Meijian; Zhao, Lianwu.
Clin. transl. oncol. (Print)
; 24(11): 2210-2221, noviembre 2022.
Artículo en Inglés | IBECS (España) | ID: ibc-210149
Documentos relacionados
Resveratrol inhibits TGF-ß1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway.
Response surface statistical optimization of fermentation parameters for resveratrol production by the endophytic fungus Arcopilus aureus and its tyrosinase inhibitory activity.
Systematic Study of Resveratrol Nanoliposomes Transdermal Delivery System for Enhancing Anti-Aging and Skin-Brightening Efficacy.
Resveratrol reduces platelet storage lesion by preventing free mitochondrial DNA (mtDNA) accumulation in platelet concentrates during storage.
Resveratrol Improves the Progression of Osteoarthritis by Regulating the SIRT1-FoxO1 Pathway-Mediated Cholesterol Metabolism.
Resveratrol reliefs DEHP-induced defects during human decidualization.
Disruptive Effects of Resveratrol on a Bacterial Pathogen of Beans.
Characterization of Cell Death Induced by Imine Analogs of Trans-Resveratrol: Induction of Mitochondrial Dysfunction and Overproduction of Reactive Oxygen Species Leading to, or Not, Apoptosis without the Increase in the S-Phase of the Cell Cycle.
A novel resveratrol analog upregulates sirtuin 1 and inhibits inflammatory cell infiltration in acute pancreatitis.
Resveratrol Promotes Diabetic Wound Healing by Inhibiting Notch Pathway.